An evaluation of antipseudomonal dosing on the incidence of treatment failure.
Brandon K HawkinsMary Joyce B WinglerDavid A CretellaKatie E BarberKayla R StoverJamie L WagnerPublished in: SAGE open medicine (2021)
Treatment failure was significantly higher in patients receiving guideline-discordant empiric antipseudomonal dosing. Guideline-directed dosing, disease states, and patient-specific factors should be assessed when considering empiric antipseudomonal dosing.